A randomized, double-blind trial of extended-release fampridine on fatigue in patients with multiple sclerosis
Latest Information Update: 08 Aug 2024
At a glance
- Drugs Fampridine (Primary)
- Indications Fatigue
- Focus Therapeutic Use
Most Recent Events
- 08 Aug 2024 New trial record
- 01 Aug 2024 Results published in the Acta Neurologica Belgica